BioSpace News Archive

Maybe they’re in a rush or have something else to do but, for whatever the reason, a survey reveals that 56% of workers say they frequently or occasionally see colleagues leave the restroom without washing up.

Beltone, a global leader in hearing care with more than 1,500 locations in the U.S., today kicked off its third annual Beltone Food Drive to help fight hunger.

According to the latest market research report released by Technavio, the global pulse oximetry market is expected to accelerate at a CAGR of almost 6% during the forecast period.

The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the EGFR Resisters, a patient-driven community of people living with epidermal growth factor receptor (EGFR) positive lung cancer and their loved ones, are working together to raise funds and increase awareness of projects that benefit the EGFR community.

On behalf of the Minister of Health, the Honourable Scott Brison, President of the Treasury Board and the Honourable Randy Delorey, Minister of Health and Wellness for Nova Scotia will sign a bilateral agreement.

FIRST (For Inspiration and Recognition of Science and Technology) today announced 12 grants to address inequities in access to science and technology.

Kicking off International Overdose Awareness week, an Illinois-based medical cannabis company launched anti-opioid campaign today highlighting real life stories of the positive impact cannabis has combating the national epidemic.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Baird 2018 Global Healthcare Conference in New York, NY.

Kala Pharmaceuticals Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, today announced that members of its management team will participate in the following upcoming conferences: